Streetbeat News

Stock Prices

JZXN

Jiuzi Holdings Inc. (JZXN) received a Nasdaq notification for not meeting the minimum bid price requirement as its shares traded below $1.00 for 30 consecutive days. The company has until May 6, 2024, to regain compliance, which can be achieved if its share price closes at $1.00 or higher for 10 consecutive business days. If JZXN fails to comply within 180 days, it may get an additional 180 days to meet the requirements, potentially through a reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:31 pm

FMC

FMC Corp (NYSE:FMC) announced during its Investor Day a strategic review of non-core assets, including the potential sale of its Global Specialty Solutions line. The company revealed plans to introduce four new synthetic ingredients and expand its biologicals platform, targeting $2 billion in revenue from each by 2033. FMC provided FY24 revenue guidance of $4.65-$4.85 billion, adjusted EBITDA of $1.025-$1.125 billion, and free cash flow conversion over 100%. FY26 revenue is projected at $5.5-$6.0 billion with adjusted EBITDA of $1.3-$1.5 billion. Shares traded lower by 0.86% at $52.97.

Portfolio Pulse from Lekha Gupta

November 17, 2023 | 4:30 pm

EXPE

Expedia's stock (EXPE) is trading higher following an upgrade from Evercore ISI, changing its rating from In-Line to Outperform.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:30 pm

MLM

Martin Marietta Materials (NYSE:MLM) has delivered an average annual return of 12.99% over the past 15 years, outperforming the market. A $100 investment in MLM 15 years ago would be worth $733.68 today. The company's market capitalization stands at $28.68 billion.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 4:30 pm

ACN

Over the past 10 years, Accenture (NYSE:ACN) has delivered an average annual return of 15.36%, outperforming the market by 5.76% on an annualized basis. A $1000 investment in ACN a decade ago would be worth $4,188.60 today. Accenture's market capitalization currently stands at $205.47 billion.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 4:30 pm

BTCW

WisdomTree has amended its spot Bitcoin ETF prospectus, indicating ongoing plans to launch an ETF with ticker BTCW, and Coinbase Custody Trust as custodian. Other firms like VanEck have also filed amended applications, while Franklin Templeton and Global X await approval deadlines. Bloomberg analysts expect further SEC delays but maintain a 90% likelihood of a spot Bitcoin ETF approval by January 2024.

Portfolio Pulse from Khyathi Dalal

November 17, 2023 | 4:29 pm

NTES

Benchmark analyst Fawne Jiang has reaffirmed a Buy rating on NetEase (NASDAQ:NTES) and increased the price target from $130 to $140.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:28 pm

SGD

Safe & Green Development Corp (NASDAQ:SGD) stock surged 84% to $5.59 after announcing it will not proceed with a previously contemplated common stock offering. The company requested the SEC to withdraw its Registration Statement and confirmed that no shares have been or will be sold under this statement. The decision was due to changed circumstances since the initial filing. The stock experienced multiple trading halts during Thursday's and Friday's sessions.

Portfolio Pulse from Henry Khederian

November 17, 2023 | 4:27 pm

PLUG

Plug Power Inc (NASDAQ:PLUG) shares dropped by 6.6% to $3.90 following a downgrade by Citigroup from Buy to Neutral and a price target reduction from $12.5 to $5. The downgrade comes after last week's Q3 financial results, which included a 'going concern' warning due to a substantial deficit, cash flow issues, and predicted losses of $3.8 billion. The company's poor performance was attributed to challenges in the hydrogen network, leading to revenue shortfalls and a net loss of 47 cents per share.

Portfolio Pulse from Henry Khederian

November 17, 2023 | 4:21 pm

BBLG

Bone Biologics Corp (NASDAQ:BBLG) stock plummeted by 38% after announcing a public offering and private placement at $0.64 per share, with additional unregistered warrants. The company aims to raise approximately $729,200 for clinical trials, patent expansion, and operational needs. The offering is expected to close around November 20, with warrants exercisable for five and a half years at $0.52 per share. H.C. Wainwright & Co. is managing the offering.

Portfolio Pulse from Henry Khederian

November 17, 2023 | 4:20 pm